These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 36599262

  • 1. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer.
    Roshan Zamir M, Ariafar A, Ghaderi A, Amirzargar A.
    Immunobiology; 2023 Mar; 228(2):152319. PubMed ID: 36599262
    [Abstract] [Full Text] [Related]

  • 2. Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients.
    Mirzazadeh S, Bemani P, Halimi H, Sanaee MN, Karami N, Ramzi M, Farjadian S.
    Sci Rep; 2023 Jul 15; 13(1):11456. PubMed ID: 37454198
    [Abstract] [Full Text] [Related]

  • 3. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.
    Tajik N, Shahsavar F, Nasiri M, Radjabzadeh MF.
    Int J Immunogenet; 2010 Jun 15; 37(3):159-68. PubMed ID: 20193031
    [Abstract] [Full Text] [Related]

  • 4. KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population.
    Tajik N, Shahsavar F, Poormoghim H, Radjabzadeh MF, Mousavi T, Jalali A.
    Int J Immunogenet; 2011 Oct 15; 38(5):403-9. PubMed ID: 21797986
    [Abstract] [Full Text] [Related]

  • 5. Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis.
    Mahmoudi M, Fallahian F, Sobhani S, Ghoroghi S, Jamshidi A, Poursani S, Dolati M, Hosseinpour Z, Gharibdoost F.
    Clin Rheumatol; 2017 Apr 15; 36(4):853-862. PubMed ID: 28120169
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Analysis of Killer Cell Immunoglobulin-Like Receptor Genes and Their HLA Ligands in Inflammatory Bowel Diseases.
    Beigmohammadi F, Mahmoudi M, Karami J, Ahmadzadeh N, Ebrahimi-Daryani N, Rezaei N.
    J Immunol Res; 2020 Apr 15; 2020():4873648. PubMed ID: 33015197
    [Abstract] [Full Text] [Related]

  • 9. Genetic profiles of killer-cell immunoglobulin-like receptors and HLA ligands in Thai blood donors.
    Kitpoka P, Tammakorn C, Chaisri S, Leelayuwat C, Mongkolsuk T, Thammanichanond D.
    Hum Immunol; 2016 Jun 15; 77(6):470-5. PubMed ID: 27131859
    [Abstract] [Full Text] [Related]

  • 10. A hybrid qPCR/SNP array approach allows cost efficient assessment of KIR gene copy numbers in large samples.
    Pontikos N, Smyth DJ, Schuilenburg H, Howson JM, Walker NM, Burren OS, Guo H, Onengut-Gumuscu S, Chen WM, Concannon P, Rich SS, Jayaraman J, Jiang W, Traherne JA, Trowsdale J, Todd JA, Wallace C.
    BMC Genomics; 2014 Apr 11; 15():274. PubMed ID: 24720548
    [Abstract] [Full Text] [Related]

  • 11. Genetic associations of killer immunoglobulin like receptors and class I human leukocyte antigens on childhood acute lymphoblastic leukemia among north Indians.
    Misra MK, Prakash S, Moulik NR, Kumar A, Agrawal S.
    Hum Immunol; 2016 Jan 11; 77(1):41-46. PubMed ID: 26472014
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease.
    Karabon L, Jedynak A, Giebel S, Wołowiec D, Kielbinski M, Woszczyk D, Kapelko-Slowik K, Kuliczkowski K, Frydecka I.
    Tissue Antigens; 2011 Aug 11; 78(2):129-38. PubMed ID: 21726204
    [Abstract] [Full Text] [Related]

  • 14. Inhibitory natural killer cell receptor KIR3DL1 with its ligand Bw4 constraints HIV-1 disease among South Indians.
    Maruthamuthu S, Rajalingam R, Pandian K, Madasamy S, Manoharan M, Pitchai L, Murugesan A, Mariakuttikan J.
    AIDS; 2018 Nov 28; 32(18):2679-2688. PubMed ID: 30289808
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Susceptibility to pulmonary tuberculosis in Iranian individuals is not affected by compound KIR/HLA genotype.
    Tajik N, Shah-hosseini A, Mohammadi A, Jafari M, Nasiri M, Radjabzadeh MF, Farnia P, Jalali A.
    Tissue Antigens; 2012 Feb 28; 79(2):90-6. PubMed ID: 22128749
    [Abstract] [Full Text] [Related]

  • 17. Activating KIR/HLA-I combinations as a risk factor of adult B-ALL.
    Halimi H, Mirzazadeh S, Kalantar K, Hajimaghsoodi M, Ramzi M, Farjadian S.
    Hum Immunol; 2024 Mar 28; 85(2):110750. PubMed ID: 38262874
    [Abstract] [Full Text] [Related]

  • 18. Analysis of killer cell immunoglobulin-like receptors and their human leukocyte antigen-ligands gene polymorphisms in Iranian patients with systemic lupus erythematosus.
    Akhtari M, Farazmand A, Mahmoudi M, Akbarian M, Ahmadzadeh N, Mirkazemi Z, Mostafaei S, Jamshidi AR.
    Lupus; 2016 Oct 28; 25(11):1244-53. PubMed ID: 26989167
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Influence of KIR genes and their HLA ligands in susceptibility to dengue in a population from southern Brazil.
    Beltrame LM, Sell AM, Moliterno RA, Clementino SL, Cardozo DM, Dalalio MM, Fonzar UJ, Visentainer JE.
    Tissue Antigens; 2013 Dec 28; 82(6):397-404. PubMed ID: 24498996
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.